awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33567077-DDFE48C6-00DB-49B2-8FC7-64E36DAED6BC
Q33567077-DDFE48C6-00DB-49B2-8FC7-64E36DAED6BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33567077-DDFE48C6-00DB-49B2-8FC7-64E36DAED6BC
Adverse drug events observed in patients with type 2 diabetes mellitus treated with 100 mg versus 300 mg canagliflozin: a systematic review and meta-analysis of published randomized controlled trials
P2860
Q33567077-DDFE48C6-00DB-49B2-8FC7-64E36DAED6BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33567077-DDFE48C6-00DB-49B2-8FC7-64E36DAED6BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5df478dfecbb58353e3bfe896c1e04d67b07284f
P2860
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus.